DR. SEVLIN BOZ

Active

Private limited companyfounded 20214 yrs activeOesterzwammenhoek 1, 1070 Anderlecht, BelgiumKBO/BCE: BE 0776.352.663

Summary

The computed 12-month bankruptcy probability of DR. SEVLIN BOZ is 3.7% (moderate). The 2025 annual accounts show equity of €424k and a net result of €129k. Equity is growing by ~54.6% per year across the filed fiscal years. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Watch Print / PDF

Checked score

Score 2025

80 / 100

Excellent

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability100=

Solvency100=

Growth78=

Track record94

Bankruptcy probability, 12 months

3.7% Moderate

0%0.5%1.5%4%10%≥ 25%

Credit up to €30k at 30 days acceptable

Liquidity ample (current ratio 21.34; short-term debt: 4.6% and cash: 94.6% of total assets), and 4.6% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

No NACE activity registered

No NACE activity is registered in the KBO, which is more common among companies that later fail.

KBO · activities

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

95.4%

Return on assets

29.1%

Age of the figures

9 mo

Filed after the deadline

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 4 filings

Deviation from the deadline

2025

31 d late

2024

21 d late

2023

on the day

2022

23 d late

← before the deadline after the deadline →

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

24-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity

€424k▲ 43.9%

2024 · €294k

2022: €71k 2023: €158k 2024: €294k

2022 → 2025

Total assets

€444k▲ 49.9%

2024 · €297k

2022: €73k 2023: €162k 2024: €297k

2022 → 2025

Net result

€129k▼ 5.3%

2024 · €136k

2022: €63k 2023: €87k 2024: €136k

2022 → 2025

Working capital

€420k▲ 45.1%

2024 · €289k

2022: €69k 2023: €154k 2024: €289k

2022 → 2025

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line2022202320242025Trend

Equity€71k-€158k▲ 123%€294k▲ 86.4%€424k▲ 43.9%

Operating result€80k-€113k▲ 40.0%€178k▲ 58.3%€176k▼ 1.4%

Net result€63k-€87k▲ 38.7%€136k▲ 56.6%€129k▼ 5.3%

Turnover and EBIT margin not published: the micro schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result falls in 2025; 2025 is 1% below 2024.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €444k

99.1%

Fixed assets €4k ▼ 24.8%

Current assets €440k ▲ 51.2%

Equity and liabilities €444k

95.4%

Equity €424k ▲ 43.9%

Debt €21k ▲ 904%

Debt's share of the balance-sheet total rises from 0.7% to 4.6%. Equity and debt are higher.

Key figures and ratios

2025 value · change against 2024

EBITDA

€178k▼

2024 · €180k

Cash flow

€132k▼

2024 · €138k

Current ratio

21.34

Debt to equity

0.05▲

2024 · 0.01

ROE

30.5%▼

2024 · 46.3%

ROA

29.1%▼

2024 · 46.0%

Interest coverage

2542.07▼

2024 · 5805.02

Debt ≤ 1 year

€21k▲

2024 · €2k

Income taxes

€46k▲

2024 · €42k

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Filed annual accounts As filed with the NBB · 2025 against 2024 · 35 lines

Balance sheet Code20242025

Assets

Total assets20/58€297k€444k▲

Fixed assets21/28€5k€4k▼

Tangible fixed assets22/27€5k€4k▼

Plant, machinery and equipment23€2k€2k▼

Furniture and vehicles24€3k€2k▼

Current assets29/58€291k€440k▲

Amounts receivable within one year40/41-€19k

Trade receivables40-€19k

Cash at bank and in hand54/58€290k€421k▲

Deferred charges and accrued income490/1€967€1k▲

Equity and liabilities

Total equity and liabilities10/49€297k€444k▲

Equity10/15€294k€424k▲

Contributions10/11€8k€8k=

Profit (loss) carried forward14€286k€416k▲

Amounts payable17/49€2k€21k▲

Amounts payable within one year42/48€2k€21k▲

Trade debts44€1k€1k▲

Suppliers440/4€1k€1k▲

Taxes, remuneration and social security45€589€4k▲

Taxes450/3€589€4k▲

Other amounts payable47/48€325€15k▲

Income statement Code20242025

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€2k▲

Other operating charges640/8€387€807▲

Gross operating margin9900€180k€179k▼

Operating profit (loss)9901€178k€176k▼

Financial income75/76B€0€0▲

Recurring financial income75€0€0▲

Financial charges65/66B€31€70▲

Recurring financial charges65€31€70▲

Profit (loss) for the period before taxes9903€178k€176k▼

Income taxes67/77€42k€46k▲

Profit (loss) for the period9904€136k€129k▼

Profit (loss) for the period to be appropriated9905€136k€129k▼

Appropriation of the result

Profit (loss) to be appropriated9906€286k€416k▲

Profit (loss) brought forward from the previous period14P€150k€286k▲

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 9Financial 4Gazette 1Filings 4

Next filing, fiscal year 2026, expected by 31-07-2027

2026

31-08

NBB filing Annual accounts filed

fiscal year 2025 · micro schema · 31 days late

26-08

State Gazette act Registered office · Statutes amendment · Resignations & appointments

Registered-office move · Name change · Power of attorney5 facts ▸

General meeting, 19-08-2026
Registered-office move, Clos des Pleurotes 1, 1070 Anderlecht
Name change, SB Therapy
Power of attorney
Powers administration, Pouvoirs à l'organe d'administration

2025

21-08

NBB filing Annual accounts filed

fiscal year 2024 · micro schema · 21 days late

2024

31-12

Financial Highest result since 2022net €136k ▲56.6%

Operating result €178k, net result €136k, both a record.

31-12

Financial Liquidity quadruplescurrent ratio 141.81

Current ratio from 35.41 to 141.81; short-term debt falls from €4k to €2k.

31-12

Financial Equity above €200kEq €294k ▲86.4%

3 profitable years in a row build equity to €294k.

31-07

NBB filing Annual accounts filed

fiscal year 2023 · micro schema

2023

31-12

Financial Equity above €150kEq €158k ▲123%

2 profitable years in a row build equity to €158k.

23-08

NBB filing Annual accounts filed

fiscal year 2022 · micro schema · 23 days late

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

2 acts for this company are in the Belgian State Gazette, of which we have read 1. We have therefore not extracted its directors from those acts yet.

Location & real-estate footprint

Registered office, Anderlecht · 1 establishment unit since 2021

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Oesterzwammenhoek 11070 Anderlecht

Ground area

8,148 m²

Building footprint

465 m²

Volume, LiDAR

10,069 m³

2 parcels, Brussels · tallest building 24.3 m, ±8 floors. Linked by address, not a title deed.

1 establishment unit

DR. SEVLIN BOZ

Hof te Ophemhoek 10, 1070 AnderlechtGeneral medical practice

since 20212.323.622.231

2 parcels

Brussels 2 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
21001A0265/00S000	Brussels	7,694 m²	1 · 458 m²	24.3 m · 8 fl.
21307G0260/00S002	Brussels	454 m²	1 · 7 m²	4.5 m · 1 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1 · via establishment units: 1

2 of 2 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification

Legal formPrivate limited company

Founded21-10-2021

Fiscal year end31-12

Legal name FR SB Therapy

Sources

Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.